Prediction of pulmonary embolism in patients with SARS-CoV-2 infection
- PMID: 34083070
- PMCID: PMC8103176
- DOI: 10.1016/j.medcli.2021.03.028
Prediction of pulmonary embolism in patients with SARS-CoV-2 infection
Abstract
Objective: To determine the predictive factors of pulmonary thromboembolic (PTE) in patients with SARS-CoV-2 infection (COVID-19) assessed in the emergency department at a tertiary hospital during the first pandemic wave.
Methods: Observational single-center study conducted in a retrospective cohort of patients with confirmed SARS-CoV-2 infection (or high clinical-radiological suspicion) who underwent PTE screening by computed tomography pulmonary angiography (CTPA). Predictive factors of PTE were explored using logistic regression, creating two predictive models (without or with D-dimer values).
Results: Out of a total of 274 CTPA performed, 70 procedures presented diagnostic findings of PTE, representing a cumulative incidence of 25.54% (95% confidence interval [CI]: 20.49-31.14). In the non-D-dimer based model, respiratory rate>22bpm (odds ratio [OR]: 3.162; 95% CI: 1.627-6.148; p=0.001) and the absence of findings suggestive of COVID-19 in plain chest X-ray (OR: 3.869; 95% CI: 0.869-17.225; p=0.076) were predictors of PTE. In the D-dimer-based model, tachypnea remained as a predictive factor (OR: 4.967; 95% CI: 2.053-12.018; p<0.001), as well as D-dimers>3,000ng/ml (OR: 7.494; 95% CI: 3.038-18.485; p<0.001).
Conclusions: The presence of tachypnea (>22bpm) and the absence of radiological findings suggestive of SARS-CoV-2 infection in the chest X-ray, in addition to D-dimer values>3,000 ng/mL, were identified as predictive factors of PTE in patients with COVID-19.
Keywords: Agentes anticoagulantes; Angiografía pulmonar por tomografía computarizada; Anticoagulant agents; COVID-19; Computed tomography pulmonary angiography; Critical illness; D-dimer; Dímero D; Embolia pulmonar; Enfermedad crítica; Pulmonary embolism.
Copyright © 2021 Elsevier España, S.L.U. All rights reserved.
Comment in
-
Prediction of pulmonary embolism in patients with SARS-CoV-2 infection.Med Clin (Barc). 2023 Feb 10;160(3):137-138. doi: 10.1016/j.medcli.2022.09.013. Epub 2022 Oct 24. Med Clin (Barc). 2023. PMID: 36379734 Free PMC article. English, Spanish. No abstract available.
References
-
- Organización Mundial de la Salud Brote de enfermedad por coronavirus. 2019 [consultado 01 Feb 2021]. Disponible en: https://www.who.int/es/emergencies/diseases/novel-coronavirus-2019.
-
- Johns Hopkins University Medicine; Coronavirus Resource Center [consultado 01 Feb 2021]. Disponible en: https://coronavirus.jhu.edu/map.html
-
- Mestre-Gómez B., Lorente-Ramos R.M., Rogado J., Franco-Moreno A., Obispo B., Salazar-Chiriboga D., et al. Incidence of pulmonary embolism in non-critically ill COVID-19 patients. Predicting factors for a challenging diagnosis. J Thromb Thrombolysis. 2021;51:40–46. doi: 10.1007/s11239-020-02190-9. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
